Microscopic Polyangiitis: Clinical Aspects
暂无分享,去创建一个
[1] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. , 2010, Arthritis and rheumatism.
[2] K. Jindal,et al. Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence-based recommendations. , 1999, Kidney international. Supplement.
[3] N. Wig,et al. Microscopic polyangiitis associated with antiphospholipid syndrome. , 1999, Rheumatology.
[4] E. Hachulla,et al. Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis. , 1999, The American journal of medicine.
[5] J. Amouroux,et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. , 1999, Arthritis and rheumatism.
[6] C. Kallenberg,et al. Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. , 1998, Journal of the American Society of Nephrology : JASN.
[7] Tidman,et al. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975–95: organ involvement, anti‐neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies , 1998, Journal of internal medicine.
[8] M. Haubitz,et al. Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] J. Ranstam,et al. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. , 1998, Journal of the American Society of Nephrology : JASN.
[10] B. Hoen,et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. , 1997, Arthritis and rheumatism.
[11] D. Adu,et al. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. , 1997, QJM : monthly journal of the Association of Physicians.
[12] C. Gordon,et al. Damage occurs early in systemic vasculitis and is an index of outcome. , 1997, QJM : monthly journal of the Association of Physicians.
[13] F. Woude,et al. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy , 1997, The Lancet.
[14] C. Gordon,et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. , 1997, Arthritis and rheumatism.
[15] F Lhote,et al. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. , 1996, British journal of rheumatology.
[16] G. Hunder,et al. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. , 1996, The American journal of medicine.
[17] D. Scott,et al. Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. , 1996, Arthritis and rheumatism.
[18] Guy Hoffman,et al. Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis , 1996, Annals of Internal Medicine.
[19] W. Gross,et al. Treatment of anti‐neutrophil cytoplasmic antibody (ANCA)‐associated systemic vasculitis with high‐dose intravenous immunoglobulin , 1995, Clinical and experimental immunology.
[20] A. Howie,et al. Vasculitis in the kidney , 1995 .
[21] Guy Hoffman,et al. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. , 1995, Arthritis and rheumatism.
[22] E. Badley,et al. Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients. , 1994, Arthritis and rheumatism.
[23] R. Moots,et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. , 1994, QJM : monthly journal of the Association of Physicians.
[24] D. Scott,et al. Classification and epidemiology of systemic vasculitis. , 1994, British journal of rheumatology.
[25] M. Heller,et al. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. , 1994, Arthritis and rheumatism.
[26] D. Adu,et al. Relapses in patients with a systemic vasculitis. , 1993, The Quarterly journal of medicine.
[27] E. Ritz,et al. In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis , 1993 .
[28] A. Douglas,et al. Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. , 1992, The Quarterly journal of medicine.
[29] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[30] Guy Hoffman,et al. Wegener Granulomatosis: An Analysis of 158 Patients , 1992, Annals of Internal Medicine.
[31] C. Pusey,et al. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. , 1991, Kidney international.
[32] M. Davies,et al. Treatment of systemic vasculitis with pooled intravenous immunoglobulin , 1991, The Lancet.
[33] Guy Hoffman,et al. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. , 1990, The American journal of medicine.
[34] J. Feehally,et al. Systemic Vasculitis in the 1980s—Is There an Increasing Incidence of Wegener's Graanulomatosis and Microscopic Polyarteritis? , 1990, Journal of the Royal College of Physicians of London.
[35] D. Scott,et al. Polyarteritis and the kidney. , 1987, The Quarterly journal of medicine.
[36] C. Savage,et al. Microscopic polyarteritis: presentation, pathology and prognosis. , 1985, The Quarterly journal of medicine.
[37] D. Scott,et al. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. , 1984, The American journal of medicine.
[38] R PLATT,et al. The kidney in periarteritis nodosa. , 1948, The Quarterly journal of medicine.
[39] T. Schleiffer,et al. Clinical course and symptomatic prediagnostic period of patients with Wegener's granulomatosis and microscopic polyangiitis. , 1998, Renal failure.
[40] O. Lortholary,et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. , 1996, Medicine.
[41] R. Falk,et al. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. , 1996, Journal of the American Society of Nephrology : JASN.
[42] C. Kallenberg,et al. Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis , 1994, Annals of Internal Medicine.
[43] V. D’Agati,et al. Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vascular and glomerular lesions. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.